GAMMA Investing’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
GAMMA Investing's EXAS Position: Q1 2026 in Review
GAMMA Investing sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 5,080 shares — an estimated $516K sold.
GAMMA Investing first reported a position in EXAS in Q4 2023 and held it in 9 quarters. The position peaked at $516K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- GAMMA Investing reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- GAMMA Investing sold 5,080 Exact Sciences shares in Q1 2026, an estimated $516K.
- GAMMA Investing first reported a position in Exact Sciences in Q4 2023 and held it in 9 quarters.
- GAMMA Investing's Exact Sciences position peaked at $516K in Q4 2025.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on GAMMA Investing's 13F filing for Q1 2026, filed 6 Apr 2026.